The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-3-(4-Methoxy-benzenesulfonyl)-1-(2-methoxy-ethyl)-6-oxo-hexahydro-pyrimidine-4-carboxylic acid hydroxyamide ID: ALA266292
PubChem CID: 44264020
Max Phase: Preclinical
Molecular Formula: C15H21N3O7S
Molecular Weight: 387.41
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COCCN1CN(S(=O)(=O)c2ccc(OC)cc2)[C@@H](C(=O)NO)CC1=O
Standard InChI: InChI=1S/C15H21N3O7S/c1-24-8-7-17-10-18(13(9-14(17)19)15(20)16-21)26(22,23)12-5-3-11(25-2)4-6-12/h3-6,13,21H,7-10H2,1-2H3,(H,16,20)/t13-/m1/s1
Standard InChI Key: SUFSQYXUPYDFHG-CYBMUJFWSA-N
Molfile:
RDKit 2D
26 27 0 0 1 0 0 0 0 0999 V2000
2.9417 -2.2625 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9417 -1.4375 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.2375 -2.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6542 -2.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6542 -3.5042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2375 -3.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9417 -3.9125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5167 -2.2667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7417 -1.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7292 -0.6375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1417 -1.6500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9417 -4.7375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.5167 -1.4417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.8042 -2.6792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.9417 -0.4292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3167 -1.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3750 -3.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3167 -0.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7292 -0.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1125 -1.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0917 -2.2667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1167 -0.5667 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0792 -5.1542 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.3667 -4.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7042 -1.1500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0792 -5.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 1 1 0
5 4 1 0
6 3 1 0
7 5 1 0
3 8 1 6
9 2 1 0
10 2 2 0
11 2 2 0
12 7 2 0
13 8 2 0
14 8 1 0
15 9 1 0
16 9 2 0
17 5 1 0
18 20 2 0
19 15 2 0
20 16 1 0
21 14 1 0
22 18 1 0
23 24 1 0
24 17 1 0
25 22 1 0
26 23 1 0
6 7 1 0
18 19 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 387.41Molecular Weight (Monoisotopic): 387.1100AlogP: -0.60#Rotatable Bonds: 7Polar Surface Area: 125.48Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.71CX Basic pKa: ┄CX LogP: -1.00CX LogD: -1.03Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.47Np Likeness Score: -1.15
References 1. Pikul S, Dunham KM, Almstead NG, De B, Natchus MG, Taiwo YO, Williams LE, Hynd BA, Hsieh LC, Janusz MJ, Gu F, Mieling GE.. (2001) Heterocycle-based MMP inhibitors with P2' substituents., 11 (8): [PMID:11327577 ] [10.1016/s0960-894x(01)00137-8 ]